About Eli

We believe people should have the power to shape their own health.

Hormones have a powerful impact on our bodies, but we have very little personal insight into how they work. Eli‘s vision to make health information accessible to women at home. Our products are evidence-based, created in collaboration with medical experts and easy to use. Eli empowers women in their health journey, at every stage.

Our Story

For us, Eli is personal.

Our co-founder, Marina, wanted a non-hormonal, non-invasive form of contraception, but couldn’t find one. This missing solution impacted her directly and showed her that without contraceptive freedom, women lack control over their own health. As she spoke to other women, she learned how a lack of hormonal data impacted them in their day-to-day lives and wellbeing. These problems ranged from cumbersome alternatives for tracking fertility, to zero solutions for perimenopause and endocrine conditions, to no clear way to track general hormonal health.

Eli was created to empower women. To offer greater control over personal health and life choices. And to provide access to evidence-based hormone insights, grounded in real-time data.

Our Team

Meet the humans behind Eli.

We are a group of experienced scientists, engineers, and founders working together with boldness, integrity and trust to solve a problem that impacts women across all stages of life. We are passionate about women’s health and working to shift the paradigm to put women’s health in their own hands.

Marina Pavlovic Rivas

Co-founder & CEO

Marina is a repeat founder passionate about empowering people with information. This passion is the unifying driver behind her diverse background that blends data science, women's health, and media. Marina founded Eli to create the solution that she, and so many others around her, needed. She founded the company after the acquisition of her previous venture, which developed machine learning solutions for organizations that empower people with information at scale. Marina has a Masters in Data Science and a Bachelor in Communications. Her work to close gender gaps also led her to create a community of over a thousand female data scientists.

Thomas Cortina

Co-founder & CTO

Thomas is a repeat founder with an interdisciplinary background in mechanical engineering and physics. He sees technology as a way to solve meaningful problems. His long-standing passion for hardware led him to build from the ground up and manufacture impactful products through his previous ventures, where he developed solid operational expertise. Thomas worked as an engineer in highly regulated and technologically complex fields, including diagnostics, robotics, and aerospace. He holds a Bachelor in Mechanical Engineering, and a Diploma in Physics focused on sensor design, which he completed in France before immigrating to North America.

Zoya Brar

Chief of Staff

Before Eli, Zoya was the founder and CEO of CORE Diagnostics, a genetics company that brought advanced testing to self-pay markets. The company served over one million patients, expanded to over a dozen countries, developed over a thousand lab tests, and scaled from two to five hundred people. She also created a one-of-a-kind work culture of complete transparency and no hierarchy. Zoya brings with her experience of diverse healthcare systems including B2B experience across channels and partnerships. Before starting CORE at 23 years old, she worked at Google and completed a Bachelor in Sociology.

James Bausano

R&D Scientist

Before Eli, James pushed the boundaries of assay development while managing assay R&D and manufacturing at a D2C at-home testing company based in San Diego. Under his lead, James’ former team put over 3 million LFA tests in the hands of consumers. Prior to that, James created in vitro assays to support vaccine development and contributed to vaccine formulation and production in the US. He loves to learn, teach, and create wherever he goes. At school, he studied Chemical Engineering.

Nelly Cheruiyot

R&D Scientist

Nelly brings a deep understanding of computational bioengineering and biological system modeling. Her industry experience extends over six years, with significant contributions to assay development and biochemical testing specializing in lateral flow and colorimetric assays. She has a Master's in Bioengineering, focusing on biostatistics and data analytics. At Eli Health, Nelly leverages her expertise to enhance our assay development processes, contributing to our mission of advancing health metrics for at-home testing.

Jocelyn Meyer

R&D Scientist

Before Eli, Jocelyn was building the infrastructure of the R&D and manufacturing teams at a D2C at-home testing company. She was instrumental in growing, training, and organizing a team of scientists and engineers that delivered over 3 million rapid tests to consumers. Jocelyn’s work in assay and product development is inspired by her desire to democratize healthcare and make the world a better place for all.

Iannick Gagnon

Machine Learning Lead

Iannick's diverse experience spans military R&D, machine learning, and consultancy, covering areas from mathematical optimization to pedagogy. As a teaching professor in Montreal, Iannick not only imparts valuable computer science knowledge but also embodies our core value of problem-solving with a dedication to creating a more inclusive world. Iannick's educational background focused on mechanical and software engineering.

Fabrice Traoré

Biomedical Specialist

Fabrice, an aerospace engineer, brings expertise from various experiences, including innovative work on rockets and solar cars. With a background that includes pivotal roles at industry giants Bombardier and Pratt & Whitney Canada, Fabrice brings experience in design and manufacturing to his current position. His passion extends beyond professional achievements; he is deeply committed to community involvement, actively participating in educational programs to share his knowledge of 3D printing and technology.

Jarred Weinberger

Biomedical Specialist

Jarred's past experience includes a stint as a manufacturing engineer where he contributed to advanced manufacturing and product development. At Eli, Jarred is instrumental in designing, rapid prototyping, and building the hardware components that are central to our innovative technology. Jarred, holds a BSc in Mechanical Engineering.

Callum Travaglini

Operations Director

Callum has vast experience in corporate development and strategy, specializing in operations, M&A, investor relations, and financial modelling. Before Eli, Callum worked directly with the CEO of a startup to scale the team from 100 to 1,200 employees. He also led fundraising for over $900M, playing a key part in driving the company's valuation from $400M to $5B. He also has experience closing several SaaS deals worth over $200M, as well as driving strategic initiatives for several portfolio companies.

Claudia Pérez-Levesque

Non-Dilutive Funding

Claudia is a four-time founder. Across her ventures, she has deployed her engineering background to create social impact and advance gender equality. In addition, she is a Co-founder of the Women in Tech Manifesto, a call for parity in the STEM industry. She has raised over $10M in non-dilutive funding for various organizations. She holds a Bachelor’s in Mechanical Engineering and a Master's in Management and Engineering.

Lena Kozarov

R&D & Operations Associate

Lena has worked as a student researcher to develop various devices for the detection of environmental contaminants and assessment of fertility markers. She gained experience in R&D engineering at a medical device startup, where she contributed to the development, verification, and design of the initial prototype. She is pursuing a Bachelor's in Bioengineering and Biomedical Engineering and co-founded CUBEC, a student conference.

Eliana Muszynski

R&D Associate

Eliana, a top graduate from McGill University's neuroscience program, excelled in diverse research, earning a place on the dean's list for her work in areas like blood-brain barrier studies and fMRI analysis of aging brains. Her ambition is to use her expertise to innovate in women's healthcare technology, aiming to make substantial contributions to the field and improve healthcare outcomes.

Our Advisors

Eli is backed by industry leaders, but not just any leaders.

Our advisors are a select group of individuals who share our goals. They’re with us every step of the way as we change the world of women’s health.

Dr. Alicia Robbins

Alicia, a board-certified OBGYN and Certified Menopause Practitioner, leverages her extensive experience in women's health to enhance well-being during midlife transitions. Practicing in Greenwich, CT, she combines lifestyle medicine with her obstetrics and surgical expertise, actively engaging in community support and advocacy for women's health. Her insights are recognized in notable outlets like Allure Magazine and The New York Times, underscoring her commitment to advancing healthcare for women.

Dr. Fady Hannah-Shmouni

Fady, an endocrinologist and clinical biochemical geneticist at the University of British Columbia, blends his medical expertise with a passion for precision medicine and longevity healthcare. As a physician-investor, he leverages his knowledge in endocrinology, genomics, and hypertension to guide ventures in precision health. At the helm of Healthspan Digital Inc, Fady focuses on developing personalized healthcare solutions through longevity biomarkers. His contributions to academia and his advisory roles in cutting-edge health ventures exemplify his commitment to advancing healthcare and improving global well-being.

Dr. Rhonda Zwingerman

Rhonda is a physician and reproductive endocrinology and infertility (REI) specialist who recently co-founded Twig Fertility. Having gone through IVF herself, Dr. Zwingerman is committed to modernizing fertility care by using best-in-class technologies and building a clinic that provides people with comprehensive and compassionate fertility care. Dr. Zwingerman sits on the REI and Genetics Committees of the Society of Obstetricians and Gynecologists of Canada (SOGC) and has co-authored the Canadian guidelines on preimplantation genetic testing. She has completed her Residency in Obstetrics & Gynecology from the University of Alberta, a Master’s in Health Policy, Management & Evaluation from University of Toronto and a Clinical Fellowship in Gynecologic Reproductive Endocrinology & Infertility from the University of Toronto.

Steve Arless

Steve Arless is one of Canada’s leading entrepreneurs in the biomedical technology industry. He directed and developed several highly regulated medical device companies from inception through major financing and public stock offering, advancing new medical devices from R&D to commercialization and global sales. He has served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD). With a passion for helping entrepreneurs flourish, Steve serves as EIR at MedTech accelerator Centech. He is also a Professor of Practice in the Faculty of Medicine at McGill University. In 2019, Steve co-founded and took the position as CEO of ViTAA Medical Solutions, a healthcare AI company.

Ruby Gadelrab Tudor

Ruby is a seasoned commercial health executive with over 20 years of experience in biotech, healthcare and healthtech industries. In the past, she served as the VP of Commercial Marketing at 23andMe, the pioneering DTC healthcare company, where she built non-consumer business models. She is currently the CEO and Co-founder of MDisrupt, a marketplace for connecting clinicians and scientists with digital health companies. In addition, she consults for companies in the genetics, healthcare and healthtech spaces on commercialization strategies. Ruby’s background includes senior executive roles developing B2B and B2C commercial strategies at high profile companies including Life Technologies, Affymetrix, and InVitae. She holds a Bachelor of Molecular Biology from UCL.

Devon C Campbell

Devon has expertise at the intersection of engineering, biology, and design. He has 22 years of experience leading the development of innovative, commercially successful medical devices, in vitro diagnostics, and companion diagnostics. In the past, he has been a product development executive at a number of organizations including startups and global healthcare companies. Devon’s background includes contributing to the Ventana acquisition by Roche for $3.4B, Novartis’ Genoptix acquisition in 2011 for $470M and Vivacta in 2012 for $90M. He was also part of the team that led to the successful IPO of Quanterix for $73.3M. He holds a Master and Bachelor of Science in Mechanical Engineering from the University of Arizona, and an Advanced Executive Certificate in Management, Innovation & Technology from MIT.

Backed by Industry Leaders

Join Our Team

Ready to change women’s health for the better?

Our (digital) doors are always open to passionate people who share our drive for change.

Dream Jobs This Way